REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. Profile Updated: August 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. is an enterprise located in Colombia, with the main office in Cartagena. It operates in the Diagnostic Imaging Centers industry. The company was established on July 15, 2005. Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. currently employs 32 (2024) people. The latest financial highlights indicate a net sales revenue increase of 90.94% in 2023. Its’ total assets recorded a growth of 7.97%. The net profit margin of Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. increased by 12.19% in 2023.

Headquarters
Centro Calle del Boquete Edif. Barbur Ofc. 201
Cartagena; Bolivar;

Contact Details: Purchase the Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. report to view the information.
Outstanding Shares:
Purchase the Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. report to view the information.
Incorporation Date:
July 15, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Bioclinico Luis Carlos Andrade Castillo E.U. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
90.94%
Total operating revenue
90.94%
Operating profit (EBIT)
208.74%
EBITDA
266.91%
Net Profit (Loss) for the Period
216.75%
Total assets
7.97%
Total equity
10.71%
Operating Profit Margin (ROS)
11.9%
Net Profit Margin
12.19%
Return on Equity (ROE)
28.93%
Quick Ratio
-0.11%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?